DE69328635D1 - Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren - Google Patents

Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren

Info

Publication number
DE69328635D1
DE69328635D1 DE69328635T DE69328635T DE69328635D1 DE 69328635 D1 DE69328635 D1 DE 69328635D1 DE 69328635 T DE69328635 T DE 69328635T DE 69328635 T DE69328635 T DE 69328635T DE 69328635 D1 DE69328635 D1 DE 69328635D1
Authority
DE
Germany
Prior art keywords
organic acid
producing
mixture containing
medicinal product
substance mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69328635T
Other languages
English (en)
Other versions
DE69328635T2 (de
Inventor
Howard Alliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69328635D1 publication Critical patent/DE69328635D1/de
Publication of DE69328635T2 publication Critical patent/DE69328635T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
DE69328635T 1992-01-21 1993-01-21 Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren Expired - Fee Related DE69328635T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82324392A 1992-01-21 1992-01-21
PCT/US1993/000544 WO1993013763A1 (en) 1992-01-21 1993-01-21 Method of treating small mouth ulcers

Publications (2)

Publication Number Publication Date
DE69328635D1 true DE69328635D1 (de) 2000-06-15
DE69328635T2 DE69328635T2 (de) 2000-09-07

Family

ID=25238195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328635T Expired - Fee Related DE69328635T2 (de) 1992-01-21 1993-01-21 Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren

Country Status (6)

Country Link
US (3) US5389679A (de)
EP (1) EP0746313B1 (de)
AT (1) ATE192646T1 (de)
CA (1) CA2128429A1 (de)
DE (1) DE69328635T2 (de)
WO (1) WO1993013763A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE192646T1 (de) * 1992-01-21 2000-05-15 Howard Alliger Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
BR9608966A (pt) 1995-06-21 1999-12-14 Extracta Ltd Uso de um hidroxì ácido, aditivo de ração, e, processo para a produção de uma ração contendoi um aditivo de ração
EP0862436A1 (de) * 1995-10-19 1998-09-09 Merck & Co., Inc. 16-substituierte-6-aza-steroid 5-alpha reduktaseinhibitoren
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
EP1585452A2 (de) * 2001-04-27 2005-10-19 Robert D. Kross Desinfizierende mundspülzusammensetzungen und verfahren zu ihrer verwendung
ATE448828T1 (de) * 2003-10-27 2009-12-15 Univ Basel Transdermales arzneimittelabgabesystem
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20060115266A1 (en) * 2004-12-01 2006-06-01 Gil Levi All-optical protection signaling systems and methods in optical communication networks
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
US8882819B2 (en) 2011-02-16 2014-11-11 Richard Crowder Handheld device for treating oral ulcers and sores
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
CN105012689A (zh) * 2015-06-29 2015-11-04 孙凤荣 一种治疗放化疗所致口腔溃疡的中药制剂
US11426372B2 (en) * 2015-11-17 2022-08-30 Francisco PAN-MONTOJO Glycolic acid protects against ischemic insults
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
WO2019232077A1 (en) 2018-05-29 2019-12-05 Chrono Therapeutics Inc. Drug delivery methods and systems

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932655A (en) * 1972-09-14 1976-01-13 International Pharmakon Laboratories, Inc. Surgical skin scrub
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4117120A (en) * 1977-02-11 1978-09-26 Elderbaum Gilbert J Medication for herpes simplex and canker sores
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4461724A (en) * 1981-10-28 1984-07-24 Nippon Zoki Pharmaceutical Co., Ltd. Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them
GB2134781B (en) * 1983-02-15 1986-02-12 Diomed Dev Ltd Composition for the treatment of stasis leg ulcers
JPS60248618A (ja) * 1984-05-24 1985-12-09 Nippon Zoki Pharmaceut Co Ltd ジペプチドを含有する潰瘍治療剤
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
ATE192646T1 (de) * 1992-01-21 2000-05-15 Howard Alliger Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren

Also Published As

Publication number Publication date
US5389679A (en) 1995-02-14
US5516799A (en) 1996-05-14
EP0746313B1 (de) 2000-05-10
WO1993013763A1 (en) 1993-07-22
EP0746313A1 (de) 1996-12-11
US5731347A (en) 1998-03-24
DE69328635T2 (de) 2000-09-07
CA2128429A1 (en) 1993-07-22
ATE192646T1 (de) 2000-05-15
EP0746313A4 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
DE69328635T2 (de) Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE357214T1 (de) Verwendung eines unverkapselten anti-krebs- wirkstoffs zur herstellung einer zubereitung zur behandlung von neoplasmen durch inhalation
ATE231519T1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ATE205389T1 (de) Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma
DE59401401D1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
HUP9800794A2 (hu) (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
BR9506748A (pt) Compostos preparação farmacêutica utilização de um composto e processos para o tratamento de um indivíduo sofrendo de dor e para a preparação de um composto
ATE183390T1 (de) Verwendung einer kombination von antineoplastonen zur herstellung eines arzneimittels zur behandlung der neurofibromatose
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
ATE254919T1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
DE69932741D1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
UA8278A (uk) Спосіб лікування псоріазу

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee